Replies to post #230031 on Cytodyn Inc (CYDY)

[kgromax]

Saying that , we don’t know what was a P-value at 14 days , I suspect it would be very good .

You have just proven that you don’t know about p-value corrections.

Because they work exactly in the opposite direction of what you have written: the more statistical tests they have performed that you don’t know about, the more the rare published p-values should have been corrected (upward), which would have made them even worse.

You have fallen into the statistical scam performed by CYDY management on gullible investors.

Note: a very basic intro to p-value corrections is here
https://en.wikipedia.org/wiki/Bonferroni_correction
These methods work by adjusting the significance threshold alpha to compensate for the multiplicity of tests performed, or, equivalently, by adjusting the p-value of each test. But it can go much further than that (alpha/beta spend etc…)
Cytodyn has confirmed they have NOT corrected p-values for multiple testing

[justdafactss]

To show 82% mortality benefit ABOVE any other drug , in 62 patients , happens only with the best .

Which drug or drugs have received FDA approval based on stats from only 62 patients?

Name at least one (1). A non reply will indicate you cant name any...

If you do reply and cant name at least one, your yodeling here is a waste of time and makes no sense.